Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer–A Pilot Study

RATIONALE AND OBJECTIVES: To explore a role for multiparametric MRI (mpMRI) as a biomarker of response to neoadjuvant androgen deprivation therapy (ADT) for prostate cancer (PCa). MATERIALS AND METHODS: This prospective study was approved by the institutional review board and was HIPAA compliant. Ei...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acad Radiol
Auteurs principaux: Fennessy, Fiona M., Fedorov, Andriy, Vangel, Mark G., Mulkern, Robert V., Tretiakova, Maria, Lis, Rosina T., Tempany, Clare, Taplin, Mary-Ellen
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297658/
https://ncbi.nlm.nih.gov/pubmed/31862185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.acra.2019.10.017
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires